BIOXODES: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIOXODES
Largest movements
- Cash +€718,527
up €718,527 (+54.5%), from €1.3m to €2.0m
mainly Short-term financial debts (+€5.8m) and Depreciation (+€1.9m)
- Receivables within one year -€710,587
down €710,587 (-83.6%), from €849,520 to €138,933
of which Other amounts receivable: -€717,728
- Intangible fixed assets +€675,383
up €675,383 (+14.1%), from €4.8m to €5.5m
- Contributions -€9.1m
down €9.1m (-95.8%), from €9.5m to €395,844
of which Outside capital: -€8.4m
- Short-term financial debts +€5.8m
new in 2025: €5.8m
- Profit (loss) carried forward +€5.6m
up €5.6m (+62.1%), from -€9.1m to -€3.4m
- Investment grants -€1.0m
down €1.0m (-42.7%), from €2.4m to €1.4m
- Other debts -€371,639
down €371,639 (-100.0%), from €371,639 to €0
- Gross operating margin +€776,159
up €776,159 (+87.3%), from -€888,611 to -€112,453
- Financial charges +€255,984
up €255,984 (+4565.9%), from €5,606 to €261,590
- Depreciation -€214,668
down €214,668 (-10.1%), from €2.1m to €1.9m
- Staff costs +€157,877
up €157,877 (+16.0%), from €987,021 to €1.1m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,990,227 | €7,681,469 | +€691,242 | +9.9% |
| Fixed assets | 21/28 | €4,810,407 | €5,485,391 | +€674,984 | +14.0% |
| Intangible fixed assets | 21 | €4,799,516 | €5,474,899 | +€675,383 | +14.1% |
| Tangible fixed assets | 22/27 | €10,717 | €10,318 | -€399 | -3.7% |
| Plant, machinery and equipment | 23 | €0 | - | = | |
| Furniture and vehicles | 24 | €8,804 | €8,740 | -€64 | -0.7% |
| Other tangible fixed assets | 26 | €1,913 | €1,578 | -€335 | -17.5% |
| Financial fixed assets | 28 | €174 | €174 | = | 0.0% |
| Current assets | 29/58 | €2,179,820 | €2,196,078 | +€16,259 | +0.7% |
| Amounts receivable within one year | 40/41 | €849,520 | €138,933 | -€710,587 | -83.6% |
| Trade receivables | 40 | €1,500 | €8,641 | +€7,141 | +476.0% |
| Other amounts receivable | 41 | €848,020 | €130,292 | -€717,728 | -84.6% |
| Cash at bank and in hand | 54/58 | €1,317,706 | €2,036,233 | +€718,527 | +54.5% |
| Deferred charges and accrued income | 490/1 | €12,594 | €20,913 | +€8,318 | +66.0% |
| Total equity and liabilities | 10/49 | €6,990,227 | €7,681,469 | +€691,242 | +9.9% |
| Equity | 10/15 | €2,807,071 | -€1,662,624 | -€4.5m | |
| Contributions | 10/11 | €9,465,050 | €395,844 | -€9.1m | -95.8% |
| Capital | 10 | €1,066,058 | €395,844 | -€670,213 | -62.9% |
| Issued capital | 100 | €1,066,058 | €395,844 | -€670,213 | -62.9% |
| Outside capital | 11 | €8,398,993 | €0 | -€8.4m | -100.0% |
| Share premium | 1100/10 | €8,398,993 | €0 | -€8.4m | -100.0% |
| Profit (loss) carried forward | 14 | -€9,069,206 | -€3,441,017 | +€5.6m | +62.1% |
| Investment grants | 15 | €2,411,227 | €1,382,549 | -€1.0m | -42.7% |
| Amounts payable | 17/49 | €4,183,156 | €9,344,093 | +€5.2m | +123.4% |
| Amounts payable after more than one year | 17 | €3,066,231 | €3,066,231 | = | 0.0% |
| Other amounts payable | 178/9 | €3,066,231 | €3,066,231 | = | 0.0% |
| Amounts payable within one year | 42/48 | €1,091,653 | €6,254,840 | +€5.2m | +473.0% |
| Financial debts | 43 | - | €5,750,471 | +€5.8m | |
| Other loans | 439 | - | €5,750,471 | +€5.8m | |
| Trade debts | 44 | €538,747 | €400,495 | -€138,251 | -25.7% |
| Suppliers | 440/4 | €538,747 | €400,495 | -€138,251 | -25.7% |
| Taxes, remuneration and social security | 45 | €181,268 | €103,874 | -€77,394 | -42.7% |
| Taxes | 450/3 | €29,844 | €3,026 | -€26,818 | -89.9% |
| Remuneration and social security | 454/9 | €151,423 | €100,848 | -€50,575 | -33.4% |
| Other amounts payable | 47/48 | €371,639 | €0 | -€371,639 | -100.0% |
| Accrued charges and deferred income | 492/3 | €25,272 | €23,022 | -€2,250 | -8.9% |
| Non-recurring operating income | 76A | - | €270 | +€270 | |
| Remuneration, social security and pensions | 62 | €987,021 | €1,144,898 | +€157,877 | +16.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,135,554 | €1,920,886 | -€214,668 | -10.1% |
| Other operating charges | 640/8 | €1,147 | €5,399 | +€4,252 | +370.9% |
| Non-recurring operating charges | 66A | €629 | €0 | -€629 | -100.0% |
| Gross operating margin | 9900 | -€888,611 | -€112,453 | +€776,159 | +87.3% |
| Operating profit (loss) | 9901 | -€4,012,963 | -€3,183,635 | +€829,328 | +20.7% |
| Financial income | 75/76B | €2,020 | €5,567 | +€3,548 | +175.7% |
| Recurring financial income | 75 | €2,020 | €5,567 | +€3,548 | +175.7% |
| Financial charges | 65/66B | €5,606 | €261,590 | +€255,984 | +4565.9% |
| Recurring financial charges | 65 | €5,606 | €261,590 | +€255,984 | +4565.9% |
| Profit (loss) for the period before taxes | 9903 | -€4,016,550 | -€3,439,658 | +€576,892 | +14.4% |
| Income taxes | 67/77 | €1,388 | €1,359 | -€29 | -2.1% |
| Profit (loss) for the period | 9904 | -€4,017,938 | -€3,441,017 | +€576,921 | +14.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€4,017,938 | -€3,441,017 | +€576,921 | +14.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.